Filter
258
Filtered Results: 258
Text search:
contraceptive
discontinuation
Featured
Recommendations
26
New Publications
85
Language
Document type
No document type
176
Studies & Reports
43
Guidelines
34
Manuals
2
Fact sheets
2
Infographics
1
Countries / Regions
India
37
Kenya
13
Rwanda
13
Zambia
10
Nepal
8
Senegal
8
Bangladesh
8
Ethiopia
8
Namibia
7
Sierra Leone
6
Malawi
6
Zimbabwe
6
Philippines
6
Ghana
5
Nigeria
5
Cambodia
5
Tanzania
5
South Africa
5
Liberia
5
Uganda
4
Haiti
3
Latin America and the Carribbean
3
Indonesia
3
Myanmar / Burma
3
Lesotho
2
Benin
2
Burkina Faso
2
Jordan
2
Western and Central Europe
2
Egypt
2
Mali
2
Botswana
2
Somalia
2
Eswatini/ Swaziland
2
Tajikistan
1
Colombia
1
Albania
1
Peru
1
Global
1
Dominican Republic
1
Congo, Democratic Republic of
1
South–East Asia Region
1
East and Southern Africa
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
163
Clinical Guidelines
23
Women & Child Health
21
Capacity Building
14
Public Health
7
Key Resources
3
Pharmacy & Technologies
1
Toolboxes
HIV
32
TB
9
Mental Health
8
COVID-19
5
Pharmacy
5
NCDs
4
NTDs
3
Refugee
2
Conflict
2
Ebola & Marburg
1
National AIDS and STI Control Program
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
These guidelines for the prevention and management of cardiovascular diseases are a critical ingredient for streamlining care across the entire health services provision continuum. They are a strategic component in achieving universal health coverage, securing affordable heal...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
Prevention Of Cardiovascular Disease: Guidelines For Assessment And Management Or Cardiocascular Risk
recommended
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
